QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
August 6, 2021 Approval gives U.S. healthcare professionals access to a new combination of scalability and speed. QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes. Each Digital eHub device, with capacity for up to 8 eSticks, can simultaneously run […]
Read More